Compare Enzyme (MLN) vs Syscoin (SYS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Syscoin — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Syscoin trades at Rp40.34 (market cap Rp53,96M, Rp18,57M 24h volume). The key difference: Enzyme is far larger — about 2.5× Syscoin's market cap, and Enzyme's circulating supply is 3,3M MLN versus 889,7M SYS for Syscoin. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Syscoin for 70 Days on average.
| MLN | SYS | |
|---|---|---|
Market Cap | Rp134,13M | Rp53,96M |
Volume (24h) | Rp104,56M | Rp18,57M |
Circulating Supply | 3,3M MLN | 889,7M SYS |
Typical Hold Time | 28 Days | 70 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently shows a market cap of Rp134,13M with 3,3jt tokens in circulation. The asset demonstrates moderate holding patterns with an average hold time of 28 days. Trading activity appears limited given the relatively small market capitalization. Recent market data suggests the token is operating in a niche segment of the cryptocurrency ecosystem with specific utility focused on decentralized finance protocols.
Overall outlook remains cautious due to limited liquidity and market depth. Key opportunities include potential ecosystem growth in DeFi sector, while major risks involve high volatility typical of small-cap cryptocurrencies and regulatory uncertainty affecting the broader crypto market. Investors should monitor on-chain activity and exchange listings for improved liquidity.
Syscoin (SYS) is a blockchain platform focusing on scalability and security, with a market cap of Rp53,96M and a circulating supply of 889,7jt tokens. Current price data is unavailable, but the asset shows a hold time of 70 days, suggesting moderate investor retention. Recent technical analysis indicates no major price movements reported, while fundamental developments remain quiet with no significant protocol updates or ecosystem news detected in the latest data.
Overall outlook is neutral with opportunities in its blockchain utility, but risks include low liquidity and market volatility. Investors should monitor for network updates and exchange activity to gauge momentum, as the absence of recent news may lead to stagnant performance without new catalysts.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Syscoin
Syscoin Platform (SYS) is a full Layer-1 and Layer-2 blockchain solution built to combine industry-proven technology to support cutting-edge applications all in one network. The project's goal is to build a protocol that transforms the blockchain experience and combines the best of Bitcoin and Ethereum.
Read more on SYS →
